H-1B sponsorship profile: MedTherapy Biotechnology Inc. Across U.S. Department of Labor LCA disclosures, MedTherapy Biotechnology Inc filed 1 Labor Condition Applications covering 1 H-1B worker positions between fiscal year 2025 and fiscal year 2025. The employer’s DOL certification rate sits at 100% (1 certified of 1 filed), a useful proxy for how cleanly their prevailing-wage attestations pass the Labor Department’s preliminary review before USCIS adjudication.

Compensation spread. Offered wages on MedTherapy Biotechnology Inc’s H-1B petitions range from $122,325 at the low end to $122,325 at the high end, with a petition-weighted average of $122,325. That range reflects the mix of occupations the company sponsors, led by Deputy General Manager (MSAT/GMP Production) (1 petitions at $122,325 avg). H-1B salaries reported on LCAs must meet or exceed the DOL prevailing wage for the role and worksite, so the spread also tracks wage-level geography and seniority.

Geographic footprint. MedTherapy Biotechnology Inc is headquartered in Quincy, MA under NAICS code 531312, and places H-1B workers across 1 state, most heavily in MA. Combined, these signals give a granular view of how one employer uses the H-1B program, volume, approval cleanliness, wage posture, and where the jobs actually sit on the map.

Where MedTherapy Biotechnology Inc ranks. By H-1B petition volume, MedTherapy Biotechnology Inc is #72,571 of 119,880 employers nationally and #3,224 of 5,193 employers headquartered in MA. Both ranks are computed live from the same underlying petition counts, not a separate estimate.